Comparative Effectiveness of Tofacitinib Versus Ustekinumab and Vedolizumab among Ulcerative Colitis Patients With Prior Anti- Tumor Necrosis Factor (TNF) Failure

First published 23/02/2022

Last updated 23/04/2024

EU PAS number:

EUPAS45035

Study

Finalised

Documents

Study protocol

Initial protocol

A3921415 Non Interventional Study Protocol Final 08Feb2022_Redacted

English (1.87 MB - PDF)View document

Updated protocol

A3921415 Non Interventional Study Protocol Amendment 1 (clean) 08Apr2022 (1)_Redacted

First published: 22/02/2024

English (1.98 MB - PDF)View document

Study results

A3921415 Non Interventional Study Report Abstract 22 December 2022_Redacted

English (1.54 MB - PDF)View document

Study report

A3921415 Non Interventional Study Report 22 December 2022_Redacted

English (4.08 MB - PDF)View document

Other information

Study, other information

A3921415 Non Interventional Study Abstract_Amendment 1 08Apr2022_Redacted

English (1.7 MB - PDF)View document

A3921415 Non Interventional Study Abstract_Final 08Feb2022_Redacted

English (1.7 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs